We demonstrated that treatment with NVP-BEZ235 caused greater apoptosis, greater apoptotic cleavage of eIF4G, and greater dephosphorylation of 4E-BP1 in primary CLL cells. The gene discussed is EIF4EBP1; the disease is B-cell chronic lymphocytic leukemia.